Sign inJoin waitlistJoin the waitlist

Back to Stanford Health Care-Sponsored Stanford University Hematology and Medical Oncology

Philip He

Hematology and Medical Oncology Fellowship · Stanford Health Care

Credentials: · ·

History

Hematology and Medical Oncology
Stanford Health Care
2026–Present
Internal Medicine
Stanford
2024–2025
University of Chicago
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
2020–2024
Harvard College

Research

Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study
Journal of Clinical Oncology · 2021 · 372 citations
Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Clinical Cancer Research · 2023 · 29 citations
Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma
Clinical Cancer Research · 2023 · 26 citations

GA
Ghassan Abou-Alfa
2 papers
Kate Kelley
2 papers
Dan Zandberg
1 paper
JB
Johanna Bendell
1 paper
Mitesh Borad
1 paper
OR
Olivier Rixe
1 paper
Robert Ferris
1 paper
Robert Haddad
1 paper
Susan Bates
1 paper
Tito Fojo
1 paper
William Harris
1 paper